Eli Lilly: Next-gen weight loss drug may be more effective than others
UPI
—
https://cdnph.upi.com/ph/st/th/6181779391660/2026/upi/9fa05160350e1d9e850bf29a0969fd5b/v1.5/Eli-Lilly-Next-gen-weight-loss-drug-may-be-more-effective-than-others.jpg" /> Eli Lilly's weight loss drug retatrutide helped nearly half of participants in a phase 3 trial to lose more than 30% of their weight after two years.
Lilly weight loss drug results
- A Next-Generation Drug Causes Dramatic Weight Loss, Eli Lilly Says Time —
- New Eli Lilly weight loss drug has dramatic effects in clinical trial Washington Examiner —
- Eli Lilly says next-gen obesity drug helps patients lose 28% of body weight - Reuters Reuters —
- New weight-loss shot appears to outperform other obesity drugs on market The Guardian —
- Eli Lilly’s next-gen obesity drug beats Ozempic and Mounjaro, helps patients lose over 30% body weight in trial The Indian Express —